WILLOW LABORATORIES

Lobbying for WILLOW LABORATORIES · technology company

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Mar 5, 2026.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Dec 15, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Health Issues

Support for coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform and corporate governance.

Medicare/Medicaid

Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies

Financial Institutions/Investments/Securities

corporate governance and transparency

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.